GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026)
GE HealthCare Technologies (GEHC) posted Liabilities and Shareholders Equity of $37.1 billion for Q1 2026, up 0.59% on a QoQ basis from $36.9 billion in Q4 2025, and up 95092.31% year-over-year from N/an in Q1 2025.
GE HealthCare Technologies (GEHC) Liabilities and Shareholders Equity (2022 - 2026) Analysis & Trends
GE HealthCare Technologies' Liabilities and Shareholders Equity history runs 5 years deep, the most recent figure standing at $37.1 billion for Q1 2026.
- Quarterly Liabilities and Shareholders Equity rose 95092.31% year-over-year to $37.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.7 billion (up 47.37% YoY) and the FY2025 annual result came in at $36.9 billion, up 11.54% from the prior year.
- Liabilities and Shareholders Equity was $37.1 billion for Q1 2026 at GE HealthCare Technologies, up from $36.9 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $37.1 billion in Q1 2026 and bottomed at $39.0 million in Q1 2025.
- A 5-year average of $31.0 billion and a median of $32.5 billion in 2023 frame the typical range for Liabilities and Shareholders Equity.
- Annual changes were most pronounced in 2025 — Liabilities and Shareholders Equity sank 99.88% — and 2026, when it surged 95092.31%.
- GE HealthCare Technologies' Liabilities and Shareholders Equity stood at $27.5 billion in 2022, then grew by 17.85% to $32.5 billion in 2023, then grew by 1.96% to $33.1 billion in 2024, then advanced by 11.54% to $36.9 billion in 2025, then grew by 0.59% to $37.1 billion in 2026.
- Business Quant data shows GEHC's Liabilities and Shareholders Equity at $37.1 billion in Q1 2026, $36.9 billion in Q4 2025, and $36.1 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.92 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.13 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.46 Bn |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 10.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.13 Bn |
| Dec 31, 2025 | 36.91 Bn |
| Sep 30, 2025 | 36.13 Bn |
| Jun 30, 2025 | 35.50 Bn |
| Mar 31, 2025 | 39.00 Mn |
| Dec 31, 2024 | 33.09 Bn |
| Sep 30, 2024 | 33.86 Bn |
| Jun 30, 2024 | 31.85 Bn |
| Mar 31, 2024 | 32.21 Bn |
| Dec 31, 2023 | 32.45 Bn |
| Sep 30, 2023 | 32.38 Bn |
| Jun 30, 2023 | 32.31 Bn |
| Mar 31, 2023 | 32.64 Bn |
| Dec 31, 2022 | 27.54 Bn |